Cargando…
An analysis report on the application of immune checkpoint inhibitors after liver transplantation
Up to now, a variety of immune checkpoint inhibitors (ICIs) have been proved to have good therapeutic effects in the treatment of hepatocellular carcinoma (HCC). However, the effects of their applications in liver transplant (LT) recipients are still unclear. In this analysis report, the clinical ap...
Autores principales: | Xie, Man, Dang, Zhi-ping, Sun, Xue-guo, Zhang, Bei, Zhang, Qun, Tian, Qiu-ju, Cai, Jin-zhen, Rao, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127875/ https://www.ncbi.nlm.nih.gov/pubmed/35620187 http://dx.doi.org/10.1177/20406223221099334 |
Ejemplares similares
-
Safety and immunogenicity of COVID-19 vaccination among liver transplant recipients in China
por: Tian, Qiu-Ju, et al.
Publicado: (2022) -
Immune checkpoint inhibitors in liver transplant: a case series
por: Rudolph, Mark, et al.
Publicado: (2023) -
Immune Checkpoint Inhibitor Therapy Before Liver Transplantation—Case and Literature Review
por: Aby, Elizabeth S., et al.
Publicado: (2022) -
Liver Transplantation for Hepatocellular Carcinoma after Downstaging or Bridging Therapy with Immune Checkpoint Inhibitors
por: Gao, Qimeng, et al.
Publicado: (2021) -
Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation
por: Katariya, Nitin N., et al.
Publicado: (2022)